Cargando…
Applications of Genetically Modified Immunobiotics with High Immunoregulatory Capacity for Treatment of Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBDs), including ulcerative colitis and Crohn’s disease, are chronic inflammatory diseases characterized by dysregulated immune responses of the gastrointestinal tract. In recent years, the incidence of IBDs has increased in developed nations, but their prophylaxis/treat...
Autores principales: | Shigemori, Suguru, Shimosato, Takeshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263139/ https://www.ncbi.nlm.nih.gov/pubmed/28179904 http://dx.doi.org/10.3389/fimmu.2017.00022 |
Ejemplares similares
-
Microbial therapeutics for acute colitis based on genetically modified Lactococcus lactis hypersecreting IL-1Ra in mice
por: Namai, Fu, et al.
Publicado: (2020) -
Oral Administration of Flavonifractor plautii Strongly Suppresses Th2 Immune Responses in Mice
por: Ogita, Tasuku, et al.
Publicado: (2020) -
Free Feeding of CpG-Oligodeoxynucleotide Particles Prophylactically Attenuates Allergic Airway Inflammation and Hyperresponsiveness in Mice
por: Okajima, Takuma, et al.
Publicado: (2021) -
The Role of Microbiota and Immunobiotics in Granulopoiesis of Immunocompromised Hosts
por: Salva, Susana, et al.
Publicado: (2017) -
Editorial: Immunobiotics—Interactions of Beneficial Microbes with the Immune System
por: Villena, Julio, et al.
Publicado: (2017)